PDO Thread Lifts

Last reviewed 15 September 2026Reviewed biannual
ThreadsMarketing claimsEvidence
Thin evidenceEvidence grade CPlausible mechanism, not enough good human data to call it.
The claim
A non-surgical lift that repositions sagging tissue and stimulates collagen, lasting one to two years.
The verdict
A small, short-lived repositioning effect that is consistently oversold as an alternative to surgery.
Worth it?
Rarely. In early, mild laxity it can buy a modest change for several months. In the face that is usually being sold on it, the money is better kept.
Jump to

What is actually happening

A polydioxanone thread is a dissolving suture with barbs or cones along it. It is passed through the subcutaneous tissue and pulled, so the barbs catch tissue and hold it in a slightly higher position. The thread itself dissolves over about six months, and the argument for a longer-lasting effect is that the fibrous reaction around it leaves behind some collagen.

What the evidence supports

Three findings come up consistently.

There is an immediate effect. Photographs taken the same day show a real change, and that is what fills the marketing.

The effect decays quickly. Most series report meaningful loss of the lift by three to six months, with a residual change that is much smaller than what was achieved on day one.

Patient satisfaction is highest in exactly the group with the least to gain: young patients with mild, early laxity and good skin quality. In the face with established descent and heavy jowls, the threads have to hold more weight against more tissue, and they hold it less well.

Why the mechanism limits it

Descent happens because the retaining ligaments allow the soft tissue to fall. A thread does not address a ligament. It creates a temporary suspension point in tissue that is still tethered where it was, and it is being asked to hold that suspension against gravity, chewing, sleeping and facial expression with a suture that is designed to disappear.

The collagen argument is where the claim gets thin. Fibrosis around a dissolving suture is real. Whether the collagen laid down along a few tracks is enough to produce a lasting lift is not established, and the studies that make the case are small, short and rarely controlled.

What actually goes wrong

Extrusion of a thread through the skin. Visible dimpling at the entry or exit points, usually settling over weeks. Asymmetry when one side holds and the other does not. Palpable, sometimes visible, cords on animation. Most of these resolve. Some require the thread to be removed, which is more involved than placing it.

The honest summary

If someone is in their thirties with early jowling, good skin and a specific event in six weeks, threads can do something worth having, provided they understand the timeline.

If someone is being offered threads as a substitute for a facelift, the question worth asking is what happens to the retaining ligaments. The answer is nothing, and that is the reason the result behaves the way it does.

What this is based on

  1. Riopelle et al., update on absorbable facial thread lifts — systematic review of 12 studies, 818 patientsDermatologic Surgery · 2025
  2. Park, three-dimensional bi-directional barbed PDO threads for midface and nasolabial fold rejuvenation — prospective studyAesthetic Plastic Surgery · 2026
  3. Rahman et al., complications in non-surgical aesthetic treatments, including thread extrusion and infection ratesAesthetic Plastic Surgery · 2025

Grades describe the quality of the human evidence, not my opinion of the treatment. Where the literature changes, the grade changes and the review date moves with it.

The full guide

All guides

Deep Plane or SMAS: What Actually Differs, and Who Each One Suits

Both operations are called facelifts and both are done by good surgeons. The difference is which anatomical layer carries the lift, and that one decision changes the look, the durability, the scar and the risk profile.

Newsletter

The one email a week that isn't selling you something.

What changed in facial rejuvenation this week, one guide we updated, and why it matters. Written by Jay Keni, MD.

A weekly email, once we launch it. We don’t sell or share addresses, and we never add patients from practice records — privacy.